Colorectal cancer (CRC) exhibits disease-relevant CD71 activity, including a non-canonical nuclear CD71 translocation that enhances nucleotide-excision–repair and tracks with aggressiveness and metastasis [131]. This evidence concerns the gene TFRC and colorectal cancer.